Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Feb 10, 2026, 4:00 PM EST

Nutra Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-1.3-1.398.18-13.1-0.77-6.59
Depreciation & Amortization
0.090.10.120.060.070.08
Other Amortization
0.130.140.540.330.130.1
Loss (Gain) From Sale of Assets
-0.04-0.04----
Stock-Based Compensation
--0.020.150.010.07
Provision & Write-off of Bad Debts
-0.110.070.07-0.160.06
Other Operating Activities
0.280.2-10.8510.66-0.465.13
Change in Accounts Receivable
-0-00.02-0.01-0-0.02
Change in Inventory
-0.02-0.040.03-0.05-0.02-0.03
Change in Accounts Payable
0.090.040.050.070.010.11
Change in Unearned Revenue
-0.070.050.18---
Change in Other Net Operating Assets
0.410.30.880.060.320.34
Operating Cash Flow
-0.43-0.55-0.76-1.74-0.88-0.74
Capital Expenditures
---0.06-0.04-0.01-
Sale of Property, Plant & Equipment
0.080.08----
Investment in Securities
-0.03----
Other Investing Activities
0.0300.09-0.25--
Investing Cash Flow
0.120.120.03-0.29-0.01-
Short-Term Debt Issued
-0.60.10.110.250.01
Long-Term Debt Issued
-0.311.222.290.740.78
Total Debt Issued
0.830.911.332.3910.79
Short-Term Debt Repaid
--0.16-0.27-0.18-0.16-0.21
Long-Term Debt Repaid
--0.31-0.42-0.08-0.01-0.01
Total Debt Repaid
-0.52-0.48-0.68-0.27-0.16-0.22
Net Debt Issued (Repaid)
0.320.430.642.130.830.57
Other Financing Activities
----0.050.18
Financing Cash Flow
0.320.430.642.130.880.74
Net Cash Flow
---0.090.09--
Free Cash Flow
-0.43-0.55-0.82-1.78-0.88-0.74
Free Cash Flow Margin
-106.46%-92.46%-187.19%-1824.84%-1703.36%-712.37%
Cash Interest Paid
0.040.090.080.0400
Levered Free Cash Flow
0.150.01-9.645.272.530.31
Unlevered Free Cash Flow
0.230.12-9.695.252.610.38
Change in Working Capital
0.410.341.160.080.30.41
Source: S&P Global Market Intelligence. Standard template. Financial Sources.